{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:07:06Z","timestamp":1762956426142,"version":"build-2065373602"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T00:00:00Z","timestamp":1600905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"Chinese Scholarship Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Microbes and New Infections"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.nmni.2020.100770","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T03:11:21Z","timestamp":1601435481000},"page":"100770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Diagnostic approaches and potential therapeutic options for coronavirus disease 2019"],"prefix":"10.1016","volume":"38","author":[{"given":"Z.","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ghafoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ualiyeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Bilal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Sajjad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7477","key":"10.1016\/j.nmni.2020.100770_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature12711","article-title":"Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor","volume":"503","author":"Ge","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.nmni.2020.100770_bib2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1473-3099(13)70690-X","article-title":"Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation","volume":"14","author":"Haagmans","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nmni.2020.100770_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.nmni.2020.100770_bib4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1136\/adc.58.7.500","article-title":"Epidemiology of coronavirus respiratory infections","volume":"58","author":"Isaacs","year":"1983","journal-title":"Arch Dis Child"},{"issue":"15","key":"10.1016\/j.nmni.2020.100770_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/cid\/ciaa345","article-title":"Quantitative detection and viral load analysis of SARS-CoV-2 in infected patients","volume":"71","author":"Yu","year":"2020","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.nmni.2020.100770_bib6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1080\/22221751.2020.1745095","article-title":"Laboratory diagnosis of emerging human coronavirus infections\u2014the state of the art","volume":"9","author":"Loeffelholz","year":"2020","journal-title":"Emerg Microbe. Infect"},{"key":"10.1016\/j.nmni.2020.100770_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jmoldx.2020.03.006","article-title":"Development of reverse transcription loop-mediated isothermal amplification assays targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","volume":"22","author":"Park","year":"2020","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.nmni.2020.100770_bib8","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J\u00a0Virol"},{"issue":"7592","key":"10.1016\/j.nmni.2020.100770_bib9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature16988","article-title":"Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer","volume":"531","author":"Walls","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nmni.2020.100770_bib10","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2014.11.021","article-title":"Host cell proteases: critical determinants of coronavirus tropism and pathogenesis","volume":"202","author":"Millet","year":"2015","journal-title":"Virus Res"},{"key":"10.1016\/j.nmni.2020.100770_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004502","article-title":"Coronavirus cell entry occurs through the endo-\/lysosomal pathway in a proteolysis-dependent manner","volume":"10","author":"Burkard","year":"2014","journal-title":"PLoS Pathogens"},{"key":"10.1016\/j.nmni.2020.100770_bib12","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1073\/pnas.0809524106","article-title":"Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites","volume":"106","author":"Belouzard","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmni.2020.100770_bib13","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1073\/pnas.1708727114","article-title":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion","volume":"114","author":"Walls","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.nmni.2020.100770_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01556-17","article-title":"Cryo-electron microscopy structure of porcine deltacoronavirus spike protein in the prefusion state","volume":"92","author":"Shang","year":"2018","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.nmni.2020.100770_bib15","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1073\/pnas.85.12.4526","article-title":"Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses","volume":"85","author":"Vlasak","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmni.2020.100770_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023710","article-title":"Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans","volume":"6","author":"Lang","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.nmni.2020.100770_bib17","doi-asserted-by":"crossref","first-page":"13221","DOI":"10.1128\/JVI.02078-14","article-title":"Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells","volume":"88","author":"Milewska","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.nmni.2020.100770_bib18","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1128\/JVI.00854-15","article-title":"Human coronavirus HKU1 spike protein uses O-acetylated sialic acid as an attachment receptor determinant and employs hemagglutinin-esterase protein as a receptor-destroying enzyme","volume":"89","author":"Huang","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.nmni.2020.100770_bib19","doi-asserted-by":"crossref","first-page":"10028","DOI":"10.1128\/JVI.00051-12","article-title":"Heparan sulfate is an attachment factor for foamy virus entry","volume":"86","author":"Plochmann","year":"2012","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.nmni.2020.100770_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fimmu.2013.00385","article-title":"Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition","volume":"4","author":"Connell","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.nmni.2020.100770_bib21","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1007\/s00018-004-4242-5","article-title":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus","volume":"61","author":"Kuhn","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.nmni.2020.100770_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/08820139309063393","article-title":"HLA class I antigen serves as a receptor for human coronavirus OC43","volume":"22","author":"Collins","year":"1993","journal-title":"Immunol Invest"},{"issue":"7440","key":"10.1016\/j.nmni.2020.100770_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.nmni.2020.100770_bib24","doi-asserted-by":"crossref","first-page":"15214","DOI":"10.1073\/pnas.1407087111","article-title":"Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein","volume":"111","author":"Millet","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmni.2020.100770_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/138161207780162971","article-title":"Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents","volume":"13","author":"Kido","year":"2007","journal-title":"Curr Pharmaceut Des."},{"year":"2020","series-title":"Cluster of pneumonia cases caused by a novel coronavirus, Wuhan, China","key":"10.1016\/j.nmni.2020.100770_bib26"},{"issue":"8","key":"10.1016\/j.nmni.2020.100770_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000003","article-title":"Why are RNA virus mutation rates so damn high?","volume":"16","author":"Duffy","year":"2018","journal-title":"PLoS Biol"},{"issue":"7","key":"10.1016\/j.nmni.2020.100770_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J\u00a0Virol"},{"year":"2020","series-title":"Patient-derived mutations impact pathogenicity of SARS-CoV-2. 2020","author":"Yao","key":"10.1016\/j.nmni.2020.100770_bib29"},{"key":"10.1016\/j.nmni.2020.100770_bib30","first-page":"258","article-title":"Implications of SARS-CoV-2 genetic diversity and mutations on pathogenicity of the COVID-19 and biomedical interventions","volume":"15","author":"Abdullahi","year":"2020","journal-title":"J\u00a0Taibah Univ Med Sci"},{"key":"10.1016\/j.nmni.2020.100770_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.nmni.2020.100770_bib32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.chom.2015.09.013","article-title":"MERS, SARS, and Ebola: the role of super-spreaders in infectious disease","volume":"18","author":"Wong","year":"2015","journal-title":"Cell Host Microbe"},{"year":"2020","series-title":"Differences by country-level income in COVID-19 cases, deaths, case-fatality rates, and rates per million population in the first five months of the pandemic","author":"Sabawoon","key":"10.1016\/j.nmni.2020.100770_bib33"},{"year":"2020","series-title":"Effects of COVID-19 pandemic on general surgical emergencies: are some emergencies really urgent? Level 1 Trauma center experience","author":"Surek","key":"10.1016\/j.nmni.2020.100770_bib34"},{"year":"2020","series-title":"Solidarity\u201d clinical trial for COVID-19 treatments","key":"10.1016\/j.nmni.2020.100770_bib35"},{"issue":"4","key":"10.1016\/j.nmni.2020.100770_bib36","doi-asserted-by":"crossref","first-page":"ofaa105","DOI":"10.1093\/ofid\/ofaa105","article-title":"Coronavirus disease 2019 treatment: a review of early and emerging options","volume":"7","author":"McCreary","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.nmni.2020.100770_bib37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"10.1016\/j.nmni.2020.100770_bib38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","article-title":"Structural basis for human coronavirus attachment to sialic acid receptors","volume":"26","author":"Tortorici","year":"2019","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.nmni.2020.100770_bib39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40261-018-0656-y","article-title":"Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review","volume":"38","author":"Plantone","year":"2018","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.nmni.2020.100770_bib40","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: an old drug against today's diseases?","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nmni.2020.100770_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13075-018-1634-8","article-title":"Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines","volume":"20","author":"Jorge","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.nmni.2020.100770_bib42","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.antiviral.2017.11.017","article-title":"An evaluation of chloroquine as a broad-acting antiviral against hand, foot and mouth disease","volume":"149","author":"Tan","year":"2018","journal-title":"Antivir Res"},{"key":"10.1016\/j.nmni.2020.100770_bib43","doi-asserted-by":"crossref","first-page":"105945","DOI":"10.1016\/j.ijantimicag.2020.105945","article-title":"Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine","volume":"55","author":"Sahraei","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.nmni.2020.100770_bib44","doi-asserted-by":"crossref","first-page":"100709","DOI":"10.1016\/j.nmni.2020.100709","article-title":"Clinical efficacy of chloroquine derivatives in COVID-19 infection: comparative meta-analysis between the big data and the real world","volume":"38","author":"Million","year":"2020","journal-title":"N Microb N Infect"},{"key":"10.1016\/j.nmni.2020.100770_bib45","doi-asserted-by":"crossref","first-page":"104228","DOI":"10.1016\/j.micpath.2020.104228","article-title":"In\u00a0vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect","volume":"145","author":"Andreani","year":"2020","journal-title":"Microb Pathog"},{"issue":"3","key":"10.1016\/j.nmni.2020.100770_bib46","first-page":"105923","article-title":"Chloroquine for the 2019 novel coronavirus SARS-CoV-2","volume":"55","author":"Colson","year":"2020","journal-title":"Int J Microb Agents"},{"key":"10.1016\/j.nmni.2020.100770_bib47","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in\u00a0vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.nmni.2020.100770_bib48","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.nmni.2020.100770_bib49","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"Grein","year":"2020","journal-title":"N\u00a0Engl J Med"},{"year":"2020","series-title":"Remdesivir investigational trials in COVID-19: a critical reappraisal","author":"Brouqui","key":"10.1016\/j.nmni.2020.100770_bib50"},{"issue":"2","key":"10.1016\/j.nmni.2020.100770_bib51","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/cpt.1844","article-title":"Favipiravir: pharmacokinetics and concerns about clinical trials for 2019-nCoV infection","volume":"108","author":"Du","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.nmni.2020.100770_bib52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc Jpn Acad Ser B, Phys Biol Sci"},{"key":"10.1016\/j.nmni.2020.100770_bib53","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/cid\/ciw571","article-title":"Clinical and virological characteristics of Ebola virus disease patients treated with favipiravir (T-705)-Sierra Leone, 2014","volume":"63","author":"Bai","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nmni.2020.100770_bib54","article-title":"Experimental treatment with favipiravir for Ebola virus disease (the JIKI trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Correction","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.nmni.2020.100770_bib55","doi-asserted-by":"crossref","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in\u00a0vitro","volume":"178","author":"Choy","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.nmni.2020.100770_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.smim.2013.12.002","article-title":"Clinical experience of IL-6 blockade in rheumatic diseases\u2014implications on IL-6 biology and disease pathogenesis","volume":"26","author":"Davies","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.nmni.2020.100770_bib57","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2020.3204","article-title":"Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore","volume":"323","author":"Young","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.nmni.2020.100770_bib58","doi-asserted-by":"crossref","first-page":"101663","DOI":"10.1016\/j.tmaid.2020.101663","article-title":"Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: a pilot observational study","volume":"34","author":"Gautret","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.nmni.2020.100770_bib59","first-page":"3390","article-title":"Clinical efficacy of lopinavir\/ritonavir in the treatment of Coronavirus disease 2019","volume":"24","author":"Ye","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.nmni.2020.100770_bib60","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650500514558","article-title":"Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia","volume":"44","author":"Chen","year":"2006","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.nmni.2020.100770_bib61","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A\u00a0trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.nmni.2020.100770_bib62","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMe2005477","article-title":"Covid-19 - the search for effective therapy","volume":"382","author":"Baden","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"Si-1","key":"10.1016\/j.nmni.2020.100770_bib63","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3906\/sag-2004-145","article-title":"Antiviral treatment of COVID-19","volume":"50","author":"\u015eim\u015fek Yavuz","year":"2020","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.nmni.2020.100770_bib64","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jiph.2016.04.001","article-title":"Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus","volume":"9","author":"Rossignol","year":"2016","journal-title":"J\u00a0Infect Public Health"},{"key":"10.1016\/j.nmni.2020.100770_bib65","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.isci.2019.07.003","article-title":"The FDA-approved oral drug nitazoxanide amplifies host antiviral responses and inhibits Ebola virus","volume":"19","author":"Jasenosky","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.nmni.2020.100770_bib66","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in\u00a0vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.nmni.2020.100770_bib67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.diagmicrobio.2019.03.012","article-title":"Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system","volume":"95","author":"Ketkar","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.nmni.2020.100770_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.berh.2012.01.001","article-title":"Tocilizumab\u2014a novel therapy for non-organ-specific autoimmune diseases","volume":"26","author":"Kaly","year":"2012","journal-title":"Best Practice Research Clin Rheumatol"},{"key":"10.1016\/j.nmni.2020.100770_bib69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cytogfr.2020.05.003","article-title":"The cytokine storm in COVID-19: an overview of the involvement of the chemokine\/chemokine-receptor system","volume":"53","author":"Coperchini","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.nmni.2020.100770_bib70","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Resp Med"},{"key":"10.1016\/j.nmni.2020.100770_bib71","series-title":"Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus","first-page":"2020","author":"Zhou","year":"2020"},{"issue":"20","key":"10.1016\/j.nmni.2020.100770_bib72","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nmni.2020.100770_bib73","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"year":"2020","series-title":"WHO, Adapted from WHO welcomes preliminary results about dexamethasone use in treating critically ill COVID-19 parents","author":"WHO","key":"10.1016\/j.nmni.2020.100770_bib74"},{"year":"2020","series-title":"Adapted from Recovery trails, randaomised evaluation of COVID-19 therapy, registered under CTN50189673","author":"Theraphy","key":"10.1016\/j.nmni.2020.100770_bib75"},{"key":"10.1016\/j.nmni.2020.100770_bib76","unstructured":"BBC n. British broadcasting coporation (BBC) news."},{"issue":"3","key":"10.1016\/j.nmni.2020.100770_bib77","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045","article-title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR","volume":"25","author":"Corman","year":"2020","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.nmni.2020.100770_bib78","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1056\/NEJMc2001737","article-title":"SARS-CoV-2 viral load in upper respiratory specimens of infected patients","volume":"382","author":"Zou","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.nmni.2020.100770_bib79","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.nmni.2020.100770_bib80","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10096-020-03913-9","article-title":"Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards","volume":"39","author":"La Scola","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.nmni.2020.100770_bib81","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2217\/fmb.13.9","article-title":"Rapid antigen-based testing for respiratory syncytial virus: moving diagnostics from bench to bedside?","volume":"8","author":"Prendergast","year":"2013","journal-title":"Future Microbiol"},{"key":"10.1016\/j.nmni.2020.100770_bib82","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1128\/JCM.01816-15","article-title":"Diagnostic accuracy of rapid antigen detection tests for respiratory syncytial virus infection: systematic review and meta-analysis","volume":"53","author":"Chartrand","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.nmni.2020.100770_bib83","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/M17-0848","article-title":"Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: a systematic review and meta-analysis","volume":"167","author":"Merckx","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nmni.2020.100770_bib84","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/JCM.42.7.2884-2889.2004","article-title":"Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay","volume":"42","author":"Lau","year":"2004","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.nmni.2020.100770_bib85","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1038\/emi.2015.26","article-title":"A\u00a0sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus","volume":"4","author":"Chen","year":"2015","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.nmni.2020.100770_bib86","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/d41587-020-00010-2","article-title":"Fast, portable tests come online to curb coronavirus pandemic","volume":"38","author":"Sheridan","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.nmni.2020.100770_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa310","article-title":"Profiling early humoral response to diagnose novel coronavirus disease (COVID-19)","author":"Guo","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nmni.2020.100770_bib88","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1155\/2006\/152612","article-title":"An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus","volume":"17","author":"Patrick","year":"2006","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.nmni.2020.100770_bib89","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(20)30196-1","article-title":"Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study","volume":"20","author":"To","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.nmni.2020.100770_bib90","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.2214\/AJR.20.22969","article-title":"Radiology perspective of coronavirus disease 2019 (COVID-19): lessons from severe acute respiratory syndrome and middle east respiratory syndrome","volume":"214","author":"Hosseiny","year":"2020","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.nmni.2020.100770_bib91","first-page":"200343","article-title":"Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing","author":"Xie","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.nmni.2020.100770_bib92","doi-asserted-by":"crossref","first-page":"100734","DOI":"10.1016\/j.nmni.2020.100734","article-title":"The first two months epidimiological study of COVID-19, related public health preparedness, and response to the ongoing epidemic in Pakistan","volume":"37","author":"Kakakhel","year":"2020","journal-title":"N Microb N Infect"}],"container-title":["New Microbes and New Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297520301220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2052297520301220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:02:24Z","timestamp":1761854544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2052297520301220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":92,"alternative-id":["S2052297520301220"],"URL":"https:\/\/doi.org\/10.1016\/j.nmni.2020.100770","relation":{},"ISSN":["2052-2975"],"issn-type":[{"type":"print","value":"2052-2975"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic approaches and potential therapeutic options for coronavirus disease 2019","name":"articletitle","label":"Article Title"},{"value":"New Microbes and New Infections","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmni.2020.100770","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100770"}}